Lineage Cell Therapeutics, Inc. (LCTX) › Shares OutstandingLineage Cell Therapeutics, Inc. (LCTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 47.78M2011: 49.04M2012: 49.38M2013: 56.71M2014: 78.23M2015: 90.42M2016: 102.78M2017: 126.87M2018: 127.14M2019: 149.80M2020: 153.10M2021: 169.48M2022: 170.09M2023: 174.99M2024: 220.42M2025: 243.12M243.12M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025243.12M+10.3%2024220.42M+26.0%2023174.99M+2.9%2022170.09M+0.4%2021169.48M+10.7%2020153.10M+2.2%2019149.80M+17.8%2018127.14M+0.2%2017126.87M+23.4%2016102.78M+13.7%201590.42M+15.6%201478.23M+37.9%201356.71M+14.8%201249.38M+0.7%201149.04M+2.6%201047.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share